Exchange: NASDAQ·Updated 07:30 PM EDT
APGE logo

APGE Apogee Therapeutics

$135.02
$0.01
(0.01%)
Today
Closed $134.97
$0.05
(0.04%)
After Hours
EarningsNov 9
Mkt Cap$10.22B
Vol733,857.00

About APGE

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in San Francisco, CA.
45

Neutral Sentiment

How do you feel about APGE?

Advertisement|Remove ads.